BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Omnicell Achieves Record Revenue in the Third Quarter 2019

  Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, today announced results for its third quarter ended September 30, 2019.

  October 24, 2019

   · 

  24 min read
• Business

  Dynavax to Report Third Quarter 2019 Financial Results and Host Conference Call on November 6

  Dynavax Technologies Corporation (NASDAQ: DVAX), a biopharmaceutical company focused on commercializing novel vaccines, will report third quarter 2019 financial results on Wednesday, November 6, 2019, after the U.S. financial markets close.

  October 24, 2019

   · 

  1 min read
• Business

  RADiant to Exhibit at the 2019 American Society for Dermatologic Surgery (ASDS) Annual Meeting in Chicago, IL

  Xstrahl Medical, global leader in superficial radiotherapy devices to treat non-melanoma skin cancer and dermatological conditions, is featuring its RADiant treatment system at the annual American Society for Dermatologic Surgery Annual Meeting in Chicago, IL from October 24th-27th, 2019 at booth #401.

  October 24, 2019

   · 

  1 min read
• Business

  Faster, Safer eRx for Independent Pediatricians

  PCC, an EHR provider, will offer the only pediatric-specific native eRx integration.

  October 24, 2019

   · 

  2 min read
• Policy

  Cognoa Launches Pivotal Study of the First Digital Diagnostic for AutismPivotal Study Results Will be Basis of a Premarket Submission to FDA

  Cognoa, a company at the forefront of pediatric behavioral health, announced initiation of its Pivotal Study to demonstrate the effectiveness of its diagnostic aid for autism spectrum disorder

  October 24, 2019

   · 

  3 min read
• Drug Development

  Rafael Pharmaceuticals Announces Expansion into South Korea of Pivotal Phase 3 Trial of CPI-613® (devimistat) in Patients with Metastatic Pancreatic Cancer

  Rafael Pharmaceuticals, Inc., a leader in the growing field of cancer metabolism-based therapeutics, announced that the Phase 3 clinical trial of CPI-613® for patients with metastatic pancreatic cancer is now active in four sites in South Korea.

  October 24, 2019

   · 

  4 min read
• Business

  CohBar to Announce 2019 Third Quarter Financial Results and Provide Business Update on November 6, 2019

  CohBar, Inc. announced that the company will release its third quarter 2019 financial results after the market closes on Wednesday, November 6, 2019.

  October 24, 2019

   · 

  4 min read
• Pharm Country

  GSK announces new events in the “Us in Lupus” campaign to reach women of color

  GSK announced new events across communities in the U.S. to reach women of color living with lupus.

  October 24, 2019

   · 

  4 min read
• Business

  Evofem Biosciences to Report Third Quarter 2019 Results and Provide Corporate Update on November 7, 2019

  Conference Call Scheduled for 11:00 a.m. EST

  October 24, 2019

   · 

  1 min read
• Biotech Beach

  Amgen To Make Repatha® (evolocumab) Available Exclusively At Its Lower List Price Option In 2020

  Repatha Original List Price Option Will be Discontinued Effective Dec. 31, 2019 Almost Half of All Medicare Patients Will Have an Affordable, Low Fixed Copay in 2020

  October 24, 2019

   · 

  13 min read